Evaluation of the efficacy of radiofrequency ablation therapy in cases with parathyroid adenoma
Turkish Journal of Medical Sciences · 12.12.2025 · 55 (6) · 1497-1503
DOI: 10.55730/1300-0144.6108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 12.12.2025. Verfasst von Bahri Evren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Faculty of Medicine, İnönü University, Malatya, Turkiye. Hauptthemen laut MEDLINE: Parathyroid Neoplasms, Radiofrequency Ablation, Adenoma, Hyperparathyroidism, Primary. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: Radiofrequency ablation of solitary parathyroid adenoma has been used to treat primary hyperparathyroidism (pHPT) in high-risk patients for parathyroidectomy. This study aimed to evaluate the clinical efficacy of radiofrequency ablation for treating pHPT in patients with parathyroid adenomas. Materials and methods: The sample for this retrospective study comprised all consecutive patients with solitary parathyroid adenoma treated with radiofrequency ablation between 2013 and 2021. Patients’ baseline serum calcium and parathyroid hormone (PTH) values were obtained. The patients were followed up with serial biochemical measurements after the intervention, then at the first-week, first-month, third-month, sixth-month, and twelfth-month follow-ups. The study’s primary outcome was a biochemical cure, defined as the reestablishment of normal serum calcium and PTH levels, persisting for at least 6 months after the ablation.
Results
The changes in the serum calcium and PTH levels were significant (p < 0.05). The biochemical cure rate was 30.2% at 1 year. At the end of 1 year, the rate of patients with normal serum calcium levels was 86.6%, whereas the rate of patients with normal serum calcium and higher PTH levels was 55.8%.
Conclusion
Radiofrequency ablation of a solitary parathyroid adenoma may be considered an alternative treatment for pHPT, given that more than half of the cases investigated in this study had normocalcemic hyperparathyroidism at 1 year.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Faculty of Medicine, İnönü University, Malatya, Turkiye.
- Department of Endocrinology, Yozgat City Hospital, Yozgat, Turkiye.
- Department of Radiology, Faculty of Medicine, İnönü University, Malatya, Turkiye.
- Department of Internal Medicine, Faculty of Medicine, Bülent Ecevit University, Zonguldak, Turkiye.
- Department of Endocrinology, Faculty of Medicine, Memorial Şişli Hospital, İstanbul, Turkiye.
ORCID-Profile: Bahri Evren, Abdulkadir Bozbay, İsmail Okan Yildirim, Ömercan Topaloğlu, İbrahim Şahin
Zitieren
APA
Evren, B., Bozbay, A., Yildirim, İ. O., Topaloğlu, Ö., & Şahin, İ. (2025). Evaluation of the efficacy of radiofrequency ablation therapy in cases with parathyroid adenoma. Turkish Journal of Medical Sciences, 55(6), 1497-1503. https://doi.org/10.55730/1300-0144.6108
Vancouver
Evren B, Bozbay A, Yildirim İO, Topaloğlu Ö, Şahin İ. Evaluation of the efficacy of radiofrequency ablation therapy in cases with parathyroid adenoma. Turkish Journal of Medical Sciences. 2025;55(6):1497-1503. doi:10.55730/1300-0144.6108
BibTeX
@article{Evren2025,
author = {Evren, Bahri and Bozbay, Abdulkadir and Yildirim, İsmail Okan and Topaloğlu, Ömercan and Şahin, İbrahim},
title = {Evaluation of the efficacy of radiofrequency ablation therapy in cases with parathyroid adenoma},
journal = {Turkish Journal of Medical Sciences},
year = {2025},
volume = {55},
number = {6},
pages = {1497--1503},
doi = {10.55730/1300-0144.6108}
}
EUVIMED